In addition to age, they analyzed local recurrence according to breast cancer subtype, and they observed higher rates of local recurrence among HER2 and triple-negative subtypes, with a trend toward higher local recurrence among patients with luminal B subtype. This evidence concerns the gene ERBB2 and breast cancer.